IRCT201206072967N4
Completed
Phase 2
Evaluation of efficacy of vaginal progesterone on pregnancy rate in women with polycystic ovarian syndrome using combination therapies for ovulation induction
Vice chancellor of research, Kashan University of Medical Sciences0 sites200 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Infertility and Polycystic Ovarian Syndrome.
- Sponsor
- Vice chancellor of research, Kashan University of Medical Sciences
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria consist 20 \-35 years, having Rotterdam criteria (having 2 from 3 following criteria: Oligomenorrehea or amenorrhea, polycystic ovaries in sonography, clinical or biochemical evidences of hyperandrogenism). The patient with abnormal hormonal assay in the third day of menstruation (including FSH, TSH, prolactin, 17 Hydroxy progesterone and testosterone), tubal obstruction in HSG or laparoscopy and infertility due to male factor will be excluded.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluation of the effect of vaginal progesterone administration on ultrasonographic indicators and fetal and pregnancy outcomes of women at high risk of preeclampsiaHigh risk pregnancy.Supervision of high risk pregnancyIRCT20151228025732N72Semnan University of Medical Sciences60
Completed
Phase 3
Evaluation of the effect of vaginal Progesterone in preventing preterm laborprevention of preterm labor.Preterm labourIRCT138706051096N1Vice Chancellor for research-Guilan University of Medical Sciences260
Recruiting
Phase 3
Comparison of the effect of vaginal progesterone on uterine Doppler findings in early-onset preeclampsiaIRCT20210127050156N1Karaj University of Medical Sciences80
Completed
Phase 2
effect of progestron in preterm laborpre term labor.Onset (spontaneous) of labour before 37 completed weeks of gestationIRCT2014123120504N1Vice chancellor for research, Tehran University of Medical Sciences182
Active, not recruiting
Phase 1
The Effect of Vaginal Progesterone Administration in the prevention of Preterm Birth in Women with Short Cervix, [also Known as: Vaginal progesterone bioadhesive gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix-Trial (PREGNANT Short Cervix-Trial)] - PREGNANT Short Cervix-TrialPreterm birth (less than or equal to 32 6/7 weeks gestation)EUCTR2008-007498-19-CZColumbia Laboratories, Inc450